Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAME.

Drmic, Domagoj et al.·World journal of gastroenterology·2017·
RPEP-032712017RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAME.
Published In:
World journal of gastroenterology, 23(29), 5304-5312 (2017)
Database ID:
RPEP-03271

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-03271·https://rethinkpeptides.com/research/RPEP-03271

APA

Drmic, Domagoj; Kolenc, Danijela; Ilic, Spomenko; Bauk, Lara; Sever, Marko; Zenko Sever, Anita; Luetic, Kresimir; Suran, Jelena; Seiwerth, Sven; Sikiric, Predrag. (2017). Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAME.. World journal of gastroenterology, 23(29), 5304-5312. https://doi.org/10.3748/wjg.v23.i29.5304

MLA

Drmic, Domagoj, et al. "Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAME.." World journal of gastroenterology, 2017. https://doi.org/10.3748/wjg.v23.i29.5304

RethinkPeptides

RethinkPeptides Research Database. "Celecoxib-induced gastrointestinal, liver and brain lesions ..." RPEP-03271. Retrieved from https://rethinkpeptides.com/research/drmic-2017-celecoxibinduced-gastrointestinal-liver-and

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.